Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8637)	2/7/1999 1:32:00 AM
From: opalapril	Read Replies (1) \| Respond to of 17367

<<Neither Neuprex [n]or BPI are being i[n]vestigated by XOMA or Bob for any use related to the above condition.>> We now have ample cause to brush off our laps, stand up, march (or swim) to Xoma's headquarters, and with a single voice demand the company start a new trial of rBPI®©™ for -- adolescent, inebriated members of the British military with psoriasis who suffer from head colds while on vacation in Bermuda. Not as small market as you may suppose. Get a life, George.